サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1375949

グリコミクスの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

Glycomics Market Size, Share & Trends Analysis Report By Product (Enzymes, Kits, Reagents, Instruments), By Application (Drug Discovery & Development, Diagnostics), By End Use, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 180 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
グリコミクスの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年10月17日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

グリコミクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のグリコミクス市場規模は2030年までに49億2,000万米ドルに達する見込みです。

2023-2030年のCAGRは14.6%と推定されます。様々な生物学的プロセスにおける重要な役割に起因するグリコミクス分野の研究開発の拡大は、世界市場を牽引すると予測されています。さらに、個別化医療に対する需要の高まりは、グリコミクスが糖鎖ベースの診断ソリューションの開発に重要な役割を果たしていることから、業界の成長をさらに後押ししています。

最近、グリコミクスは、さまざまな健康状態の早期発見と診断のための疾患特異的な糖鎖バイオマーカーの同定に有望であることが示されています。糖鎖バイオマーカーの可能性は、ヘルスケアおよび診断業界からの関心を集めています。例えば、2021年11月、GlycoPath Inc.は臨床および研究サンプルのグライコプロテオーム解析用の糖鎖イメージングキットを発売しました。新たに発売されたキットは、組織イメージングから生体流体プロファイリングまで適用可能で、多くの種類のプラットフォームに容易に適応できます。

技術の進歩もグリコミクス装置の高い需要に貢献しています。タンパク質の特性解析のような調査は、化学・生化学研究における質量分析（MS）、高速液体クロマトグラフィー（HPLC）、キャピラリー電気泳動（CE）のような先端技術へと進化しています。これらの高度な技術は、迅速かつ正確な結果を提供します。現在利用可能なグリコミクス技術は標準化され、合理化されています。

さらに、糖鎖ベースの研究を支援する研究機関の増加が、近い将来の市場成長を促進すると予想される主な要因です。National Center for Biomedical Glycomics（NCBG）は、分析ゲノミクスのための技術とツールの普及と開発に注力しています。同センターの分析技術研究開発プログラムでは、糖鎖ツール、糖鎖複合体、インフォマティクスの開発が行われています。さらに、国立がん研究センターは、がん研究のための糖鎖生物学者連合（Alliance of Glycobiologists for Cancer Research）で構成されており、がん研究のための糖鎖の構造と機能の研究を目的としています。

グリコミクス市場レポートハイライト

  • 2022年には酵素分野が29.2%の収益シェアで業界を支配し、これは糖鎖ベースの研究、診断、創薬における酵素の幅広い応用に起因しています。
  • 創薬および薬剤開発は市場最大の用途であり、診断分野はグリカンベースの診断法開発に対する業界プレイヤーの関心の高まりにより、最も速い成長が見込まれています。
  • 最終用途分野では、学術・研究機関分野が38.2％の収益シェアで市場を独占しています。高い収益成長は、研究センターによるグリカン構造データ解析の広範な採用や、トレーニングおよび教育目的でのグリコミクスへの嗜好の高まりに起因しています。
  • 北米地域は、2022年の世界市場を39.1%の収益シェアで支配しました。同地域の高成長は、多数の研究機関の存在や政府の支援法などの要因に支配されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 製品別ビジネス分析

  • グリコミクス市場：製品変動分析
  • 酵素
    • 酵素市場、2018～2030年
    • グリコシダーゼ
    • 糖転移酵素
    • ノイラミニダーゼ
    • シアル酸転移酵素
    • その他
  • キット
    • キット市場、2018～2030年
    • 糖鎖標識キット
    • 糖鎖精製キット
    • 糖鎖放出キット
    • その他のグライコミックキット
  • 試薬
    • 試薬市場、2018～2030年
    • 糖タンパク質
    • 単糖類
    • オリゴ糖
    • その他の試薬
  • 機器
    • 機器市場、2018～2030年
    • 質量分析計
    • HPLC
    • MALDI-TOF
    • アレイシステム
    • その他

第5章 用途別ビジネス分析

  • グリコミクス市場：用途の変動分析
  • 創薬と開発
  • 診断
  • その他

第6章 最終用途別ビジネス分析

  • グリコミクス市場： 最終用途の変動分析
  • 製薬およびバイオテクノロジー企業
    • 製薬およびバイオテクノロジー企業市場、2018年から2030年
  • 学術調査機関
    • 学術調査機関の市場、2018年から2030年
  • バイオ医薬品企業
    • バイオ医薬品企業市場、2018年から2030年
  • CRO
    • CRO市場、2018～2030年

第7章 地域別ビジネス分析

  • 地域別のグリコミクス市場シェア、2022年および2030年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市場シェア/地位分析、2022年
  • 企業プロファイル・一覧表
    • Thermo Fisher Scientific, Inc
    • Merck KGaA
    • Agilent Technologies Inc.
    • Bruker
    • New England Biolabs
    • Shimadzu Corporation
    • Waters Corporation
    • Takara Bio Inc
    • Asparia Glycomics
    • RayBiotech Life, Inc.
図表

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 5 Global Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 6 Global Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 7 Global Glycomics Market, By Region, 2018 - 2030 (USD Million)
  • TABLE 8 North America Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 9 North America Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 10 North America Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 11 North America Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 12 U.S. Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 13 U.S. Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 14 U.S. Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 15 Canada Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 16 Canada Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 17 Canada Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 18 Europe Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 19 Europe Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 20 Europe Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 21 Europe Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 22 UK Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 23 UK Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 24 UK Glycomics Market, By End-Use, 2018 - 2030 (USD Million),
  • TABLE 25 Germany Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 26 Germany Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 27 Germany Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 28 France Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 29 France Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 30 France Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 31 Spain Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 32 Spain Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 33 Spain Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 34 Italy Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 35 Italy Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 36 Italy Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 37 Denmark Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 38 Denmark Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 39 Denmark Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 40 Norway Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 41 Norway Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 42 Norway Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 43 Sweden Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 44 Sweden Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 45 Sweden Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 47 Asia Pacific Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 48 Asia Pacific Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 49 Asia Pacific Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 50 China Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 51 China Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 52 China Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 53 Japan Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 54 Japan Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 55 Japan Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 56 India Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 57 India Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 58 India Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 59 South Korea Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 60 South Korea Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 61 South Korea Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 62 Australia Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 63 Australia Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 64 Australia Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 65 Thailand Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 66 Thailand Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 67 Thailand Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 68 Latin America Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 69 Latin America Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 70 Latin America Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 71 Latin America Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 72 Brazil Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 73 Brazil Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 74 Brazil Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 75 Mexico Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 76 Mexico Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 77 Mexico Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 78 Argentina Glycomics Market, By Product, 2018 - 2030 (USD Million),
  • TABLE 79 Argentina Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 80 Argentina Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 81 MEA Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 82 MEA Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 83 MEA Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 84 MEA Glycomics Market, By End-Use, 2018 - 2030 (USD Million),
  • TABLE 85 South Africa Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 86 South Africa Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 87 South Africa Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 88 UAE Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 89 UAE Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 90 UAE Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 91 Saudi Arabia Glycomics Market, By Product, 2018 - 2030 (USD Million),
  • TABLE 92 Saudi Arabia Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 93 Saudi Arabia Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 94 Kuwait Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 95 Kuwait Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 96 Kuwait Glycomics Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 glycomics market segmentation
  • FIG. 8 Market snapshot, 2022
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 PESTEL analysis
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Global glycomics market: Product movement analysis
  • FIG. 15 Global glycomics market, for enzymes, 2018 - 2030 (USD Million)
  • FIG. 16 Global glycomics market, for glycosidases, 2018 - 2030 (USD Million)
  • FIG. 17 Global glycomics market, for glycosyltransferases, 2018 - 2030 (USD Million)
  • FIG. 18 Global glycomics market, for neuraminidases, 2018 - 2030 (USD Million)
  • FIG. 19 Global glycomics market, for sialyltransferases, 2018 - 2030 (USD Million)
  • FIG. 20 Global glycomics market, for others, 2018 - 2030 (USD Million)
  • FIG. 21 Global glycomics market, for kits, 2018 - 2030 (USD Million)
  • FIG. 22 Global glycomics market, for glycan labeling kits, 2018 - 2030 (USD Million)
  • FIG. 23 Global glycomics market, for glycan purification kits, 2018 - 2030 (USD Million)
  • FIG. 24 Global glycomics market, for glycan release kits, 2018 - 2030 (USD Million)
  • FIG. 25 Global glycomics market, for other glycomics kits, 2018 - 2030 (USD Million)
  • FIG. 26 Global glycomics market, for reagents, 2018 - 2030 (USD Million)
  • FIG. 27 Global glycomics market, for glycoproteins, 2018 - 2030 (USD Million)
  • FIG. 28 Global glycomics market, for monosaccharides, 2018 - 2030 (USD Million)
  • FIG. 29 Global glycomics market, for oligosaccharides, 2018 - 2030 (USD Million)
  • FIG. 30 Global glycomics market, for other reagents, 2018 - 2030 (USD Million)
  • FIG. 31 Global glycomics market, for instruments, 2018 - 2030 (USD Million)
  • FIG. 32 Global glycomics market, for mass spectrometers, 2018 - 2030 (USD Million)
  • FIG. 33 Global glycomics market, for HPLC, 2018 - 2030 (USD Million)
  • FIG. 34 Global glycomics market, for MALDI-TOF, 2018 - 2030 (USD Million)
  • FIG. 35 Global glycomics market, for array systems, 2018 - 2030 (USD Million)
  • FIG. 36 Global glycomics market, for others, 2018 - 2030 (USD Million)
  • FIG. 37 Global glycomics market: Application movement analysis
  • FIG. 38 Global glycomics market, for drug discovery & development, 2018 - 2030 (USD Million)
  • FIG. 39 Global glycomics market, for diagnostics, 2018 - 2030 (USD Million)
  • FIG. 40 Global glycomics market, for others, 2018 - 2030 (USD Million)
  • FIG. 41 Global glycomics market: End Use movement analysis
  • FIG. 42 Global glycomics market, for academic & research institutes, 2018 - 2030 (USD Million)
  • FIG. 43 Global glycomics market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • FIG. 44 Global glycomics market, for biopharmaceutical companies, 2018 - 2030 (USD Million)
  • FIG. 45 Global glycomics market, for CROs, 2018 - 2030 (USD Million)
  • FIG. 46 Regional marketplace: Key takeaways
  • FIG. 47 Regional outlook, 2022 & 2030
  • FIG. 48 Global glycomics market: Region movement analysis
  • FIG. 49 North America glycomics market, 2018 - 2030 (USD Million)
  • FIG. 50 U.S. glycomics market, 2018 - 2030 (USD Million)
  • FIG. 51 Canada glycomics market, 2018 - 2030 (USD Million)
  • FIG. 52 Europe glycomics market, 2018 - 2030 (USD Million)
  • FIG. 53 Germany glycomics market, 2018 - 2030 (USD Million)
  • FIG. 54 UK glycomics market, 2018 - 2030 (USD Million)
  • FIG. 55 France glycomics market, 2018 - 2030 (USD Million)
  • FIG. 56 Italy glycomics market, 2018 - 2030 (USD Million)
  • FIG. 57 Spain glycomics market, 2018 - 2030 (USD Million)
  • FIG. 58 Denmark glycomics market, 2018 - 2030 (USD Million)
  • FIG. 59 Sweden glycomics market, 2018 - 2030 (USD Million)
  • FIG. 60 Norway glycomics market, 2018 - 2030 (USD Million)
  • FIG. 61 Asia Pacific glycomics market, 2018 - 2030 (USD Million)
  • FIG. 62 Japan glycomics market, 2018 - 2030 (USD Million)
  • FIG. 63 China glycomics market, 2018 - 2030 (USD Million)
  • FIG. 64 India glycomics market, 2018 - 2030 (USD Million)
  • FIG. 65 Australia glycomics market, 2018 - 2030 (USD Million)
  • FIG. 66 South Korea glycomics market, 2018 - 2030 (USD Million)
  • FIG. 67 Thailand glycomics market, 2018 - 2030 (USD Million)
  • FIG. 68 Latin America glycomics market, 2018 - 2030 (USD Million)
  • FIG. 69 Brazil glycomics market, 2018 - 2030 (USD Million)
  • FIG. 70 Mexico glycomics market, 2018 - 2030 (USD Million)
  • FIG. 71 Argentina glycomics market, 2018 - 2030 (USD Million)
  • FIG. 72 Middle East and Africa glycomics market, 2018 - 2030 (USD Million)
  • FIG. 73 South Africa glycomics market, 2018 - 2030 (USD Million)
  • FIG. 74 Saudi Arabia glycomics market, 2018 - 2030 (USD Million)
  • FIG. 75 UAE glycomics market, 2018 - 2030 (USD Million)
  • FIG. 76 Kuwait glycomics market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-452-9

Glycomics Market Growth & Trends:

The global glycomics market size is expected to reach USD 4.92 billion by 2030, according to a new report by Grand View Research, Inc.. The market is estimated to register a CAGR of 14.6% during 2023-2030. Growing research and development in the glycomics space, owing to its crucial role in various biological processes, is projected to drive the global market. Moreover, the increasing demand for personalized medicine has further supported industry growth as glycomics plays a significant role in developing glycan-based diagnostic solutions.

Recently glycomics have shown promise in identifying disease-specific glycan biomarkers for early detection and diagnosis of various health conditions. The potential for glycan biomarkers has attracted interest from the healthcare and diagnostics industries. For instance, in November 2021 GlycoPath Inc. launched its glycan imaging kit for glycoproteomic analysis of clinical and research samples. The newly launched kit is applicable for tissue imaging to biofluid profiling and is easily adaptable with many kinds of platforms.

Technological advancements have also contributed to the high demand for glycomics instruments. Procedures such as protein characterizations are evolving into advanced technologies such as Mass Spectrometry (MS), High-Performance Liquid Chromatography (HPLC), and Capillary Electrophoresis (CE) in chemical and biochemical research. These advanced techniques provide rapid and precise results. Glycomics technologies currently available are standardized and streamlined.

Furthermore, the increase in the number of research institutes that support glycan-based research is a major factor anticipated to fuel market growth in the near future. The National Center for Biomedical Glycomics (NCBG) focuses on the dissemination & development of technologies and tools for analytical genomics. The organization's analytical, technical R&D program involves the development of glycan tools, glycoconjugate, and informatics. In addition, the National Cancer Institute consists of the Alliance of Glycobiologists for Cancer Research, which aims at studying the structure as well as functions of glycans for cancer study.

Glycomics Market Report Highlights:

  • Enzymes segment dominated the industry in 2022 with a revenue share of 29.2% and is attributed to the wide application of enzymes in glycan-based studies, diagnostics, and drug discovery
  • Drug discovery and development is the largest application of the market, whereas the diagnostics segment is expected to witness the fastest growth owing to the growing interest of industry players in developing glycan-based diagnostics
  • In the end-use segment, the academic & research institutes segment dominated the market with a revenue share of 38.2%. The higher revenue growth is attributed to the extensive adoption of glycan structure data analysis by research centers and the increasing preference for glycomics for training & educational purposes
  • North America region dominated the global market in 2022 with a revenue share of 39.1%. The high growth of the region is governed by factors such as the presence of a large number of research institutes and supportive government legislation.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definition
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
    • 1.4.1. Objective 1
    • 1.4.2. Objective 2
    • 1.4.3. Objective 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing focus on glycomics and proteomics research
      • 3.2.1.2. Rising R & D investments by pharmaceutical and biotechnology companies
      • 3.2.1.3. Technological advancements
      • 3.2.1.4. Increasing focus on developing alternative to animal testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of glycomics instruments
      • 3.2.2.2. Stringent government policies and regulations
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Glycomics Market: Product Movement Analysis
  • 4.2. Enzymes
    • 4.2.1. Enzymes Market, 2018 - 2030 (USD Million)
    • 4.2.2. Glycosidases
      • 4.2.2.1. Glycosidases Market, 2018 - 2030 (USD Million)
    • 4.2.3. Glycosyltransferases
      • 4.2.3.1. Glycosyltransferases Market, 2018 - 2030 (USD Million)
    • 4.2.4. Neuraminidases
      • 4.2.4.1. Neuraminidases Market, 2018 - 2030 (USD Million)
    • 4.2.5. Sialyltransferases
      • 4.2.5.1. Sialyltransferases Market, 2018 - 2030 (USD Million)
    • 4.2.6. Others
      • 4.2.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. Kits
    • 4.3.1. Kits Market, 2018 - 2030 (USD Million)
    • 4.3.2. Glycan labeling kits
      • 4.3.2.1. Glycan labeling kits Market, 2018 - 2030 (USD Million)
    • 4.3.3. Glycan purification kits
      • 4.3.3.1. Glycan purification kits Market, 2018 - 2030 (USD Million)
    • 4.3.4. Glycan release kits
      • 4.3.4.1. Glycan release kits Market, 2018 - 2030 (USD Million)
    • 4.3.5. Other glycomics kits
      • 4.3.5.1. Other glycomics kits Market, 2018 - 2030 (USD Million)
  • 4.4. Reagents
    • 4.4.1. Reagents Market, 2018 - 2030 (USD Million)
    • 4.4.2. Glycoproteins
      • 4.4.2.1. Glycoproteins Market, 2018 - 2030 (USD Million)
    • 4.4.3. Monosaccharides
      • 4.4.3.1. Monosaccharides Market, 2018 - 2030 (USD Million)
    • 4.4.4. Oligosaccharides
      • 4.4.4.1. Oligosaccharides Market, 2018 - 2030 (USD Million)
    • 4.4.5. Other reagents
      • 4.4.5.1. Other reagents Market, 2018 - 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments Market, 2018 - 2030 (USD Million)
    • 4.5.2. Mass spectrometers
      • 4.5.2.1. Mass spectrometers Market, 2018 - 2030 (USD Million)
    • 4.5.3. HPLC
      • 4.5.3.1. HPLC Market, 2018 - 2030 (USD Million)
    • 4.5.4. MALDI-TOF
      • 4.5.4.1. MALDI-TOF Market, 2018 - 2030 (USD Million)
    • 4.5.5. Array systems
      • 4.5.5.1. Array systems Market, 2018 - 2030 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Glycomics Market: Application Movement Analysis
  • 5.2. Drug Discovery & Development
    • 5.2.1. Drug Discovery & Development Market, 2018 - 2030 (USD Million)
  • 5.3. Diagnostics
    • 5.3.1. Diagnostics Market, 2018 - 2030 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. Glycomics Market: End Use Movement Analysis
  • 6.2. Pharmaceutical & Biotechnology Companies
    • 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.4. Biopharmaceutical Companies
    • 6.4.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.5. CROs
    • 6.5.1. CROs Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Glycomics Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Glycomics Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target Disease Prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. U.S. Glycomics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Canada Glycomics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. UK Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Germany Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. France Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Italy Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Spain Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Denmark Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Sweden Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Norway Glycomics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Japan Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. China Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. India Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Australia Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Thailand Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. South Korea Glycomics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Glycomics Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Brazil Glycomics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Mexico Glycomics Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Argentina Glycomics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Glycomics Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. South Africa Glycomics Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Saudi Arabia Glycomics Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. UAE Glycomics Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Kuwait Glycomics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share/Position Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Agilent Technologies Inc.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Bruker
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. New England Biolabs
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Shimadzu Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Waters Corporation
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Takara Bio Inc
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Asparia Glycomics
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. RayBiotech Life, Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives